Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel (MATTIS-D)

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified June 2013 by Rabin Medical Center
Sponsor:
Collaborators:
Tel Aviv Medical Center
Sheba Medical Center
Meir Medical Center
Rambam Health Care Campus
Information provided by (Responsible Party):
eli lev, Rabin Medical Center
ClinicalTrials.gov Identifier:
NCT01643031
First received: July 15, 2012
Last updated: June 14, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: October 2014
  Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)